Trazodone for Sleep Management

Guideline-Based Recommendations

The American Academy of Sleep Medicine does not recommend trazodone for initial insomnia treatment 1
Preferred first-line agents include zolpidem, eszopiclone, or zaleplon for sleep onset issues 1
Trazodone at a low dose has not demonstrated significant improvement in sleep quality, reducing sleep latency by only a short period compared to placebo 1

Trazodone may be considered for PTSD-associated nightmares, though data are low-grade and sparse 2, 3
In a retrospective cohort of patients, trazodone decreased nightmare frequency from several nights/week to fewer nights/week 2, 3
The mean effective dose was a moderate dose per day 2, 3
However, a significant percentage of patients experienced side effects, including daytime sedation, dizziness, and headache, and some discontinued due to intolerable effects 2, 3

First-line treatment includes zolpidem, eszopiclone, or zaleplon at bedtime 1
If first-line treatments fail or are contraindicated, consider alternative treatments for sleep onset issues 1
For patients with comorbid depression or anxiety, alternative treatments may be preferable to trazodone 1
For PTSD nightmares specifically, trazodone may be considered after weighing side effect risks 2, 3

Serious adverse events include a rare but serious condition requiring immediate medical attention 2, 3
Side effects are dose-dependent, with drowsiness being most common 2, 3

Do not use trazodone as routine first-line for primary insomnia 1
Do not combine trazodone with alcohol or other sedatives 1
Educate male patients about the risk of a rare but serious condition requiring emergency care 2, 3
Adjust to lower doses in elderly patients 1